The Federal Trade Commission is scrutinizing Amazon’s Prime business model, and has also reviewed the tech giant’s other potential deals, such as the acquisition of Metro-Goldwyn Mayer Studios and a new deal with iRobot which makes autonomous vacuums, for anti-trust violations.
That doesn’t necessarily mean Amazon’s recent $3.9 billion purchase of San Francisco-based One Medical, which provides membership-based telehealth and in-person…